Imagin Molecular Corporation (IMGM) news stock charts
Imagin Molecular Corporation (IMGM/IMGM.OB) Investment Summary:
Imagin Molecular Corporation, through its subsidiaries, engages in the manufacture of positron emission tomography (PET) devices; the ownership of PET imaging center; and the diagnosis and treatment of cancer, heart, and neurological diseases. It provides myocardial perfusion imaging technology, and related technical and educational services to diagnose and treat patients with coronary artery disease, and patients who are at risk of developing coronary heart disease. The company also offers cardiovascular PET and noninvasive coronary artery disease reversal programs to general/family/internal medicine physicians in the United States. In addition, it manufactures PET scanners. The company is ...www.imaginmolecularcorp.com
2 Employees
IMAGIN MOLECULAR CORP (IMGM:OTC Bulletin Board Market)
LAST $0.05 USD
CHANGE TODAY -0.003 -5.66%
VOLUME 10.0K
As of 8:10 PM 03/19/10 All times are local (Market data is delayed by at least 15 minutes).
Snapshot of IMAGIN MOLECULAR CORP (IMGM)
|
OPEN
$0.05
|
PREVIOUS CLOSE
$0.05
|
|
|
DAY HIGH
$0.05
|
DAY LOW
$0.05
|
|
|
52 WEEK HIGH
12/24/09 - $0.16
|
52 WEEK LOW
12/17/09 - $0.0050
|
|
|
MARKET CAP
3.7M
|
AVERAGE VOLUME 10 D
15.6K
|
|
|
EPS TTM
$-0.03
|
SHARES OUTSTANDING
74.4M
|
|
|
IMGM Does Not Pay Dividends
|
P/E TTM
--
|
|
| K = Thousands M = Millions B = Billions | ||
Key developments for IMAGIN MOLECULAR CORP (IMGM)
Imagin Molecular Corporation Reports Earnings Results for the First Quarter Ended March 31, 2009
05/20/2009
Imagin Molecular Corporation reported earnings results for the first quarter ended March 31, 2009. The company reported net loss of $136,940. In contrast, the company posted a net loss of $20,134 for the same quarter in the previous year.
Imagin Molecular Corporation announced delayed 10-Q filing
05/18/2009
On 05/18/2009, Imagin Molecular Corporation announced that they will be unable to file their next 10-Q by the deadline required by the SEC.
Imagin Molecular Corporation Auditor Raises 'Going Concern' Doubt
04/15/2009
Imagin Molecular Corporation filed its 10-K on April 15, 2009 for the period ending December 31, 2008. In this report its auditor, Frank L. Sassetti & Co, gave an unqualified opinion expressing doubt that the company can continue as a going concern.
Imagin Molecular Corporation financial resources
IMGM Competitors
| Company | Last | Change | |
| No competitor information is available for IMGM. | |||
| Market data is delayed at least 15 minutes. | |||
Industry Analysis
| Valuation | IMGM | Industry Range |
| Price/Earnings | NM | Not Meaningful |
| Price/Sales | 24.3x |
|
| Price/Book | NM | Not Meaningful |
| Price/Cash Flow | NM | Not Meaningful |
| TEV/Sales | 21.3x |
|
|
IMGM |
||
|
IMGM transactions
| Type Date |
Target |
|
Merger/Acquisition
December 23, 2009 |
Planet Green Bottle Corporation |
More Recent Financial News About Imagin Molecular Corporation
IMAGIN Molecular Corporation to Acquire Planet Green Bottle Corporation
2010-01-15 03:47:46
Quote: Read article
IMAGIN Molecular Corporation to Acquire Planet Green Bottle Corporation
2009-12-24 04:04:19
Quote: Read article
IMAGIN MOLECULAR CORP Files SEC form 10-Q, Quarterly Report
2009-11-30 02:59:12
Quote: Management's Discussion And Analysis Of Financial Condition And Results
Of Operation
Overview
Imagin Molecular Corporation refocused its business strategy in April 2005 to
concentrate on business opportunities in positron emission tomography (PET)
through holdings in strategically related divisions based in the manufacturing
of PET devices ownership of PET imaging center and the diagnosis and treatment
of cancer, heart and neurological diseases. PET is an advanced medical
diagnostic imaging...Read article
IMAGIN MOLECULAR CORP Files SEC form 10KSB/A, Annual Report
2009-11-30 02:59:12
Quote: MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS
OF OPERATIONS
Overview
Imagin Molecular Corporation refocused its business strategy in April 2005 to
concentrate on business opportunities in positron emission tomography (PET)
through holdings in strategically related divisions based in the manufacturing
of PET devices ownership of PET imaging center and the diagnosis and treatment
of cancer, heart and neurological diseases. PET is an advanced medical
diagnostic imagin...Read article
IMAGIN MOLECULAR CORP Files SEC form 10-K/A, Annual Report
2009-11-30 02:59:11
Quote: MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS
OF OPERATIONS
Overview
Imagin Molecular Corporation has focused its business strategy to concentrate on
business opportunities in positron emission tomography (PET) through holdings in
strategically related divisions based in the manufacturing of PET devices
ownership of PET imaging center and the diagnosis and treatment of cancer, heart
and neurological diseases. PET is an advanced medical diagnostic imaging
procedure ...Read article
IMAGIN MOLECULAR CORP Files SEC form 10-K, Annual Report
2009-11-30 02:59:11
Quote: MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS
OF OPERATIONS
Overview
Imagin Molecular Corporation has focused its business strategy to concentrate on
business opportunities in positron emission tomography (PET) through holdings in
strategically related divisions based in the manufacturing of PET devices
ownership of PET imaging center and the diagnosis and treatment of cancer, heart
and neurological diseases. PET is an advanced medical diagnostic imaging
procedure ...Read article
IMAGIN MOLECULAR CORP Files SEC form 10-K/A, Annual Report
2009-11-30 02:59:11
Quote: MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS
OF OPERATIONS
Overview
Imagin Molecular Corporation refocused its business strategy in April 2005 to
concentrate on business opportunities in positron emission tomography (PET)
through holdings in strategically related divisions based in the manufacturing
of PET devices ownership of PET imaging center and the diagnosis and treatment
of cancer, heart and neurological diseases. PET is an advanced medical
diagnostic imagin...Read article
Would you like to leave a comment about Imagin Molecular Corporation IMGM/IMGM.OB
Find out what social network information about Imagin Molecular Corporation are available on RealpenniesWorst 5 - Click here to find out what stocks have been voted down by our visitors and users
Besides Imagin Molecular Corporation's Stock there is more great penny stock and market information at Realpennies